I speculate that RAC have a background activity working on an oral formulation combining Zantrene and ASTX727 (note ASTX747 is a typo).
https://www.asx.com.au/asxpdf/20211101/pdf/452fm1vcm8f2j0.pdf
![]()
https://astx.com/research-developme...azuridine-astx727-hematological-malignancies/
Otsuka have their own program developing an oral combination - from the above link:
![]()
So I'm wondering if there will be an oral formulation combining decitabine, cedazuridine and Zantrene once data to help determine optimal dosage is generated.
![]()
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing & updated presentation
Ann: Race investor briefing & updated presentation, page-335
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.63 |
Change
-0.030(1.81%) |
Mkt cap ! $278.5M |
Open | High | Low | Value | Volume |
$1.66 | $1.66 | $1.63 | $25.11K | 15.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1755 | $1.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.65 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1755 | 1.620 |
4 | 8654 | 1.615 |
1 | 950 | 1.610 |
1 | 2000 | 1.605 |
3 | 14925 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.645 | 1500 | 1 |
1.675 | 13792 | 2 |
1.680 | 647 | 1 |
1.690 | 5585 | 2 |
1.700 | 17181 | 1 |
Last trade - 10.52am 26/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |